Fig. 4From: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapyTherapeutic evaluation of DC-iMBs in TNBC bearing humanized immune system mice. a Schematic outline of the experimental design and timeline adopted for treatment, imaging, and blood collection. b (i-iv) Relative change in tumor volume over time. Black arrows indicate the starting date of therapeutic treatments. c Animals from different treatment groups measured for body weight over time (n = 4/group) to monitor the impact of treatments on animal health as well as xGVHD development. d Survival curves of animals from different treatment groups. All data are shown as Mean ± SD. *p < 0.05; **p < 0.005; ***p < 0.0001Back to article page